Literature DB >> 28902544

Using All Means to Protect Public Health in Israel From Emerging Tobacco Products.

Eran Kopel1, Nadav Davidovitch1, Hagai Levine1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28902544      PMCID： PMC5607691          DOI： 10.2105/AJPH.2017.304016

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  7 in total

1.  IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation.

Authors:  Carla J Berg; Katelyn F Romm; Yael Bar-Zeev; Lorien C Abroms; Katharina Klinkhammer; Christina N Wysota; Amal Khayat; David A Broniatowski; Hagai Levine
Journal:  Tob Control       Date:  2021-10-19       Impact factor: 6.953

2.  Assessment of IQOS Marketing Strategies at Points-of-Sale in Israel at a Time of Regulatory Transition.

Authors:  Yael Bar-Zeev; Carla J Berg; Lorien C Abroms; Maya Rodnay; Daniel Elbaz; Amal Khayat; Hagai Levine
Journal:  Nicotine Tob Res       Date:  2022-01-01       Impact factor: 5.825

3.  Informing iQOS Regulations in the United States: A Synthesis of What We Know.

Authors:  Carla J Berg; Yael Bar-Zeev; Hagai Levine
Journal:  Sage Open       Date:  2020-01-09

4.  Historic tobacco legislation in Israel: a moment to celebrate.

Authors:  L Rosen; S Kislev; Y Bar-Zeev; H Levine
Journal:  Isr J Health Policy Res       Date:  2020-05-04

5.  Revolution or redux? Assessing IQOS through a precursor product.

Authors:  Jesse Elias; Lauren M Dutra; Gideon St Helen; Pamela M Ling
Journal:  Tob Control       Date:  2018-10-10       Impact factor: 7.552

6.  IQOS point-of-sale marketing strategies in Israel: a pilot study.

Authors:  Yael Bar-Zeev; Hagai Levine; Gil Rubinstein; Ihab Khateb; Carla J Berg
Journal:  Isr J Health Policy Res       Date:  2019-01-14

7.  Knowledge and risk perceptions of Israelis towards combustible cigarettes: the need for immediate remedial action.

Authors:  Laura J Rosen; David A Rier; Robert Schwartz; Michal Talitman; Lior Zwanziger
Journal:  Isr J Health Policy Res       Date:  2019-01-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.